Cell Biotech Co., Ltd. (KOSDAQ:049960)

Market Cap	90.07B
Revenue (ttm)	48.10B
Net Income (ttm)	13.94B
Shares Out	6.84M
EPS (ttm)	2,035.91
PE Ratio	6.46
Forward PE	n/a
Dividend	450.00 (3.43%)
Ex-Dividend Date	Dec 27, 2024

Volume	7,051
Average Volume	15,482
Open	12,900
Previous Close	12,830
Day's Range	12,700 - 12,980
52-Week Range	11,650 - 16,950
Beta	0.66
RSI	43.70
Earnings Date	Aug 13, 2025

About Cell Biotech

Cell Biotech Co., Ltd., a biotechnology company, develops lactic acid bacteria products in South Korea and internationally. It engages in the probiotics, microbiome, and anticancer new drug businesses. The company sells its products through partnerships with multinational companies and local retailers under the DUOLAC, DUOLAB, LACTOClear, and LAB2PRO brand names. Cell Biotech Co., Ltd. was founded in 1995 and is based in Gimpo, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1995
• Employees: 106
• Stock Exchange: KOSDAQ
• Ticker Symbol: 049960

Financial Performance

In 2024, Cell Biotech's revenue was 49.91 billion, a decrease of -7.20% compared to the previous year's 53.79 billion. Earnings were 15.13 billion, an increase of 139.96%.